The economic tea leaves look favorable
Design and test potential COVID-19 treatments from your phone
Excluding pregnant women from COVID-19 vaccine trials puts their health at risk
Raymond James Says These 3 Stocks Could Surge Over 100% From Current Levels
Buy the rumour, sell the fact
Eli Lilly pauses trial of Covid-19 antibody drug over safety concern
J&J pauses Covid-19 vaccine trials
NIH study aims to identify promising COVID-19 treatments for larger clinical trials
Pfizer, BioNTech Ink Deal To Supply 1.5M Covid Vaccines To New Zealand
Sorrento Adds Stem Cell Treatment To Covid-19 Pipeline; Shares Rise
Takeda group begins manufacturing Covid-19 plasma treatment ahead of approval
Operation Warp Speed Boss Projects Covid-19 Vaccine EUA by Thanksgiving
South Korea’s Daewoong Pharma gets approval for Phase 1 trials of Covid-19 anti-parasite drug
3 COVID-19 Antibody Stocks That Are Leading the Race
Spotlight on COVID-19 antibody therapies after Trump’s recovery
UK study tests if BCG vaccine protects against Covid
AstraZeneca Inks $486M US Support For Covid-19 Antibody Cocktail
Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does
Cedars-Sinai to study unequal impact of COVID-19 on minorities
Global Trial Launches to Test Remdesivir with hIVIG in Covid-19
What you – and doctors – should watch for if you have COVID-19
Takeda-led Covid-19 plasma treatment enters clinical trial with first patient
BioNTech, Rentschler Partner For Covid-19 Vaccine Manufacturing
NIH trial testing hyperimmune intravenous immunoglobulin and remdesivir to treat COVID-19
Canada’s COVID-19 Vaccine Task Force needs better transparency about potential conflicts of interest
Gilead Inks EU Supply Deal For 500,000 Remdesivir Doses
Government needs strategy to kick-start R&D after COVID, says pharma body
Company of the Year 2020: Bristol-Myers Squibb — Patience Rewarded
Gilead 2020: HIV … and COVID?
Amgen 2020: 40-Year-Old Pioneer